Target intelligence / Profile preview

Bismuth-sensitive bacterial and mucosal targets

Molecular classification
Enzyme, Bacterial cell wall, Mucosal glycoprotein, Cyclooxygenase, Other
01

Overview

Bismuth-sensitive bacterial and mucosal targets represent a diverse group of molecular sites that mediate the therapeutic effects of bismuth salts in treating gastrointestinal disorders. These targets include essential bacterial enzymes such as urease and F1-ATPase, which are critical for the survival of Helicobacter pylori, as well as bacterial cell wall components and iron-acquisition siderophores (PubMed, 2015; Nature Microbiology, 2024). On the host side, bismuth ions interact with gastric mucosal glycoproteins to precipitate and form a protective physical barrier over ulcerated tissue, shielding it from the aggressive effects of gastric acid and pepsin (NIH, 2025; droracle.ai, 2026). Furthermore, bismuth stimulates the endogenous synthesis of prostaglandins and bicarbonate, which enhance the mucosal defense and promote tissue repair (Semanticscholar.org, 2025). In formulations like bismuth subsalicylate, the salicylate component targets cyclooxygenase enzymes to provide additional anti-inflammatory and antisecretory benefits (patsnap.com, 2024). This multi-pronged mechanism makes bismuth salts effective in eradicating infections, protecting the gut lining, and managing symptoms of diarrhea and dyspepsia (WebMD, 2025).

Other names
Bismuth targetsGastroprotective bismuth targetsAntimicrobial bismuth targetsBismuth-sensitive microbial and host targets
02

Mechanism of action

Bismuth salts act via a multi-targeted approach: they exert direct bactericidal effects by inhibiting essential enzymes such as urease, alcohol dehydrogenase, and F1-ATPase, and by disrupting iron uptake through the blocking of siderophores in pathogens like Helicobacter pylori (PubMed, 2015; Nature Microbiology, 2024). Simultaneously, they provide mucosal protection by binding to gastric glycoproteins to form a physical barrier over ulcers, stimulating prostaglandin and bicarbonate secretion, and neutralizing bacterial toxins (NIH, 2025; droracle.ai, 2026). In subsalicylate forms, they also inhibit cyclooxygenase enzymes to provide anti-inflammatory and antisecretory effects (patsnap.com, 2024; Wikipedia, 2024).

03

Biological functions

Antimicrobial activityMucosal protectionProstaglandin synthesis stimulationToxin neutralizationFluid absorption
04

Disease associations

InfectionInflammationPeptic ulcer diseaseDiarrhea
05

Safety considerations

Bismuth encephalopathyBlack tongueBlack stoolsReye's syndromeSalicylate toxicityRenal insufficiency
06

Interacting drugs

Bismuth subsalicylate

3 more in the full profile.

07

Biomarkers

Helicobacter pylori eradicationUrea breath testStool antigen testStool frequency

Beyond the preview

Go deeper on Bismuth-sensitive bacterial and mucosal targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bismuth-sensitive bacterial and mucosal targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call